BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34843106)

  • 1. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
    Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
    Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
    Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.
    Gheorghe A; Maringe C; Spice J; Purushotham A; Chalkidou K; Rachet B; Sullivan R; Aggarwal A
    Eur J Cancer; 2021 Jul; 152():233-242. PubMed ID: 34049776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study.
    Parmar A; Eskander A; Sander B; Naimark D; Irish JC; Chan KKW
    CMAJ; 2022 Mar; 194(11):E408-E414. PubMed ID: 35314440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
    Alagoz O; Lowry KP; Kurian AW; Mandelblatt JS; Ergun MA; Huang H; Lee SJ; Schechter CB; Tosteson ANA; Miglioretti DL; Trentham-Dietz A; Nyante SJ; Kerlikowske K; Sprague BL; Stout NK;
    J Natl Cancer Inst; 2021 Nov; 113(11):1484-1494. PubMed ID: 34258611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
    Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
    Degeling K; Baxter NN; Emery J; Jenkins MA; Franchini F; Gibbs P; Mann GB; McArthur G; Solomon BJ; IJzerman MJ
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):359-367. PubMed ID: 33567163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
    Lai AG; Pasea L; Banerjee A; Hall G; Denaxas S; Chang WH; Katsoulis M; Williams B; Pillay D; Noursadeghi M; Linch D; Hughes D; Forster MD; Turnbull C; Fitzpatrick NK; Boyd K; Foster GR; Enver T; Nafilyan V; Humberstone B; Neal RD; Cooper M; Jones M; Pritchard-Jones K; Sullivan R; Davie C; Lawler M; Hemingway H
    BMJ Open; 2020 Nov; 10(11):e043828. PubMed ID: 33203640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Population-Based Analysis of Diabetes-Related Care Measures, Foot Complications, and Amputation During the COVID-19 Pandemic in Ontario, Canada.
    de Mestral C; Gomez D; Wilton AS; Lee DS; Albalawi Z; Austin PC; Jacob-Brassard J; Urbach DR; Al-Omran M; Baxter NN
    JAMA Netw Open; 2022 Jan; 5(1):e2142354. PubMed ID: 34985514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
    Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
    JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
    Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
    JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ophthalmic surgical backlog associated with the COVID-19 pandemic: a population-based and microsimulation modelling study.
    Felfeli T; Ximenes R; Naimark DMJ; Hooper PL; Campbell RJ; El-Defrawy SR; Sander B
    CMAJ Open; 2021; 9(4):E1063-E1072. PubMed ID: 34815262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the Incidence of New-Onset Anorexia Nervosa and Atypical Anorexia Nervosa Among Youth During the COVID-19 Pandemic in Canada.
    Agostino H; Burstein B; Moubayed D; Taddeo D; Grady R; Vyver E; Dimitropoulos G; Dominic A; Coelho JS
    JAMA Netw Open; 2021 Dec; 4(12):e2137395. PubMed ID: 34874405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.
    Hartman HE; Sun Y; Devasia TP; Chase EC; Jairath NK; Dess RT; Jackson WC; Morris E; Li P; Hochstedler KA; Abbott MR; Kidwell KM; Walter V; Wang M; Wang X; Zaorsky NG; Schipper MJ; Spratt DE
    JAMA Oncol; 2020 Dec; 6(12):1881-1889. PubMed ID: 33119036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19.
    Mullangi S; Aviki EM; Chen Y; Robson M; Hershman DL
    JAMA Netw Open; 2022 Jul; 5(7):e2224296. PubMed ID: 35900758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.